US Patent 9127064 Antibodies against human NKG2D and uses thereof
Patent 9127064 was granted and assigned to Novo Nordisk on September, 2015 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 15, 2008
Date of Patent
September 8, 2015
Patent Application Number
12747095
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9127064 Antibodies against human NKG2D and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
